Roche and BioMed X, a collaboration model at the interface between academia and industry based in Heidelberg, Germany, have entered into a collaboration agreement to establish a research group focusing on the development of a novel sensor technology platform based on new nanomaterials such as graphene.
Outstanding early career scientists from academic institutions worldwide are invited to submit original project proposals in biotechnology, nanotechnology and engineering. Roche and BioMed X will jointly select the best ideas and research talents to form a new research group within BioMed X's open innovation lab in Heidelberg.
BioMed X has developed a unique innovation model offering a project plan competition, a funding package, entrepreneurial education and guidance by experienced mentors from academia and industry. BioMed X's open innovation lab is part of the multi-disciplinary life science campus of the University of Heidelberg, which provides an interdisciplinary environment for project teams.
The supportive setting of BioMed X provides an opportunity for the winners of the project plan competition to combine state-of-the-art nanomaterials research with biomedical know-how in order to develop a new sensor technology platform for near-patient testing.
BioMed X will be responsible for the operation of the innovation center facility, providing entrepreneurial education and enabling access to the Heidelberg scientific community and research facilities.
Further details of the agreement and financial terms have not been disclosed.